Dr. Edita Botonjic-Sehic is Head of Process Analytics and Data Science at ReciBioPharm, where she leads the strategic implementation of process analytical technology (PAT), data engineering, and data science for continuous bioprocessing. With over 20 years of experience, she has advanced manufacturing concepts in pharmaceutical and therapeutic development. Previously, she was Director of PAT at Pall Life Sciences and Cytiva, and part of the PAT team at GlaxoSmithKline for API development. She also led PAT efforts at TEVA Pharmaceuticals and served as principal investigator on DHS- and DoD-funded projects at Morpho Detection, developing detection systems for trace and bulk materials. Dr. Botonjic-Sehic holds a PhD in Analytical Chemistry from the University of Rhode Island and dual undergraduate degrees in chemistry and mathematics from Assumption College. She recently completed a business analytics program at Harvard Business School and is a recognized leader, frequent speaker, and published author in advanced technology and data science.